— Know what they know.
Not Investment Advice

GPFT OTC

Grapefruit USA, Inc.
1W: -33.3% 1M: +0.0% 3M: -80.0% YTD: -84.8% 1Y: -80.0% 3Y: -96.5% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±108.6%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 45 · $71740 mcap · 460M float · 2.52% daily turnover · Short 32% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$21K +91.1% ▲
Operating Income
-$260K +71.9% ▲
Net Income
-$1M +34.2% ▲
EPS (Diluted)
$-0.00 +47.6% ▲
EBITDA
-$254K +53.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$4M$589K$40K$200$0
YoY Growth+713.8%-84.0%-93.2%-99.5%-100.0%
Cost of Revenue$3M$1M$504K$237K$21K
Gross Profit$280K-$530K-$464K-$237K-$21K
Gross Margin7.6%-90.0%-1166.2%-118500.0%—
R&D Expenses$0$0$0$0$0
SG&A Expenses$1M$2M$2M$689K$239K
Operating Expenses$1M$2M$2M$689K$239K
Operating Income-$1M-$2M-$2M-$926K-$260K
Operating Margin-32.8%-410.2%-5514.5%-463000.0%—
Interest Expense$2M$2M$1M$1M$966K
Income Before Tax-$4M-$6M-$4M-$2M-$1M
Tax Expense$0$0$0$0$0
Net Income-$4M-$6M-$4M-$2M-$1M
Net Margin-110.5%-934.7%-9493.3%-925000.0%—
EPS (Diluted)$-0.01$-0.01$-0.01$-0.00$-0.00
EBITDA-$2M-$3M-$2M-$549K-$254K
Shares Outstanding498M515M671M901M1.11B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms